[Form 4] Cardinal Health, Inc. Insider Trading Activity
Jason M. Hollar, identified as Chief Executive Officer, filed a Form 4 for Cardinal Health, Inc. (CAH) reporting a transaction dated 08/12/2025. The filing shows an acquisition of 245,420 common shares recorded as performance share units that the filer states will settle on August 15, 2025. The reported price is $0 and the filing lists 437,235 shares beneficially owned following the reported transaction. The form is signed by James E. Barnett, Attorney-in-fact on 08/12/2025.
Jason M. Hollar, identificato come Chief Executive Officer, ha depositato un Form 4 per Cardinal Health, Inc. (CAH) relativo a una transazione datata 08/12/2025. La segnalazione riporta l'acquisizione di 245,420 azioni ordinarie registrate come performance share units che, secondo il dichiarante, saranno liquidate il 15 agosto 2025. Il prezzo indicato 猫 $0 e il documento elenca 437,235 azioni possedute beneficiariamente dopo la transazione. Il modulo 猫 firmato da James E. Barnett, procuratore (Attorney-in-fact) in data 08/12/2025.
Jason M. Hollar, identificado como Director Ejecutivo, present贸 un Formulario 4 para Cardinal Health, Inc. (CAH) que informa una transacci贸n con fecha 08/12/2025. La presentaci贸n muestra una 补诲辩耻颈蝉颈肠颈贸苍 de 245,420 acciones ordinarias registradas como performance share units que, seg煤n el declarante, se liquidar谩n el 15 de agosto de 2025. El precio informado es $0 y la presentaci贸n indica que hay 437,235 acciones en posesi贸n beneficiosa tras la transacci贸n. El formulario est谩 firmado por James E. Barnett, apoderado (Attorney-in-fact) el 08/12/2025.
Jason M. Hollar, 斓滉碃瓴届榿鞛�(Chief Executive Officer)搿� 頇曥澑霅橂┌, Cardinal Health, Inc. (CAH)鞐� 雽�頃� Form 4毳� 鞝滌稖頃橃棳 瓯半灅鞚检潉 08/12/2025搿� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 旆摑鞙茧 245,420欤检潣 氤错喌欤缄皜 performance share units搿� 旮半霅橃柎 鞛堨溂氅�, 鞝滌稖鞚胳潃 鞚措摛鞚� 2025雲� 8鞗� 15鞚检棎 鞝曥偘霅� 瓴�鞚措澕瓿� 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 氤搓碃霅� 臧�瓴╈潃 $0鞚措┌, 鞝滌稖靹滌棎電� 氤搓碃霅� 瓯半灅 頉� 鞁れ鞝侅溂搿� 氤挫湢頃� 欤检嫕鞚� 437,235欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 鞏戩嫕鞚� James E. Barnett, 雽�毽澑(Attorney-in-fact)鞐� 鞚橅暣 08/12/2025鞐� 靹滊獏霅橃棃鞀惦媹雼�.
Jason M. Hollar, identifi茅 comme Chief Executive Officer, a d茅pos茅 un Formulaire 4 pour Cardinal Health, Inc. (CAH) d茅clarant une transaction dat茅e du 08/12/2025. Le d茅p么t indique une acquisition de 245,420 actions ordinaires comptabilis茅es comme des performance share units qui, selon le d茅clarant, seront r茅gl茅es le 15 ao没t 2025. Le prix d茅clar茅 est de $0 et le dossier mentionne 437,235 actions d茅tenues 脿 titre b茅n茅ficiaire apr猫s la transaction. Le formulaire est sign茅 par James E. Barnett, mandataire (Attorney-in-fact) le 08/12/2025.
Jason M. Hollar, ausgewiesen als Chief Executive Officer, reichte ein Form 4 f眉r Cardinal Health, Inc. (CAH) ein und meldete eine Transaktion mit Datum 08/12/2025. Die Einreichung weist einen Erwerb von 245,420 Stammaktien aus, die als Performance-Share-Einheiten verbucht wurden und die nach Angaben des Meldenden am 15. August 2025 abgewickelt werden. Der angegebene Preis betr盲gt $0 und das Formular nennt 437,235 Aktien, die nach der gemeldeten Transaktion wirtschaftlich gehalten werden. Das Formular ist am 08/12/2025 von James E. Barnett, Bevollm盲chtigter (Attorney-in-fact) unterschrieben.
- Reporting person identified: Jason M. Hollar is listed as Chief Executive Officer of Cardinal Health.
- Transaction details disclosed: Acquisition of 245,420 common shares (performance share units) with settlement on August 15, 2025, and 437,235 shares beneficially owned after the transaction.
- None.
Insights
TL;DR: CEO Jason Hollar reported receipt of 245,420 performance-based common shares, increasing reported beneficial ownership to 437,235 shares.
The Form 4 shows a non-cash acquisition of 245,420 common shares recorded as performance share units that will settle on August 15, 2025. The transaction date and the filing date are both 08/12/2025, and the reported price is $0, consistent with equity grants rather than open-market purchases. Beneficial ownership following the transaction is reported as 437,235 shares. From a securities perspective, this is a routine insider equity award disclosure rather than an open-market trading signal.
TL;DR: The CEO disclosed a grant-settling award; the filing documents grant terms and resulting beneficial ownership but contains no unusual governance actions.
The filing identifies the reporting person as the company CEO and documents a grant-style transaction described as performance share units to be settled on August 15, 2025. The Form 4 includes the standard explanatory remark and a signature by an attorney-in-fact. There is no amendment indicated and no derivative transactions reported. This disclosure fulfills Section 16 reporting obligations for an equity award.
Jason M. Hollar, identificato come Chief Executive Officer, ha depositato un Form 4 per Cardinal Health, Inc. (CAH) relativo a una transazione datata 08/12/2025. La segnalazione riporta l'acquisizione di 245,420 azioni ordinarie registrate come performance share units che, secondo il dichiarante, saranno liquidate il 15 agosto 2025. Il prezzo indicato 猫 $0 e il documento elenca 437,235 azioni possedute beneficiariamente dopo la transazione. Il modulo 猫 firmato da James E. Barnett, procuratore (Attorney-in-fact) in data 08/12/2025.
Jason M. Hollar, identificado como Director Ejecutivo, present贸 un Formulario 4 para Cardinal Health, Inc. (CAH) que informa una transacci贸n con fecha 08/12/2025. La presentaci贸n muestra una 补诲辩耻颈蝉颈肠颈贸苍 de 245,420 acciones ordinarias registradas como performance share units que, seg煤n el declarante, se liquidar谩n el 15 de agosto de 2025. El precio informado es $0 y la presentaci贸n indica que hay 437,235 acciones en posesi贸n beneficiosa tras la transacci贸n. El formulario est谩 firmado por James E. Barnett, apoderado (Attorney-in-fact) el 08/12/2025.
Jason M. Hollar, 斓滉碃瓴届榿鞛�(Chief Executive Officer)搿� 頇曥澑霅橂┌, Cardinal Health, Inc. (CAH)鞐� 雽�頃� Form 4毳� 鞝滌稖頃橃棳 瓯半灅鞚检潉 08/12/2025搿� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 旆摑鞙茧 245,420欤检潣 氤错喌欤缄皜 performance share units搿� 旮半霅橃柎 鞛堨溂氅�, 鞝滌稖鞚胳潃 鞚措摛鞚� 2025雲� 8鞗� 15鞚检棎 鞝曥偘霅� 瓴�鞚措澕瓿� 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 氤搓碃霅� 臧�瓴╈潃 $0鞚措┌, 鞝滌稖靹滌棎電� 氤搓碃霅� 瓯半灅 頉� 鞁れ鞝侅溂搿� 氤挫湢頃� 欤检嫕鞚� 437,235欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 鞏戩嫕鞚� James E. Barnett, 雽�毽澑(Attorney-in-fact)鞐� 鞚橅暣 08/12/2025鞐� 靹滊獏霅橃棃鞀惦媹雼�.
Jason M. Hollar, identifi茅 comme Chief Executive Officer, a d茅pos茅 un Formulaire 4 pour Cardinal Health, Inc. (CAH) d茅clarant une transaction dat茅e du 08/12/2025. Le d茅p么t indique une acquisition de 245,420 actions ordinaires comptabilis茅es comme des performance share units qui, selon le d茅clarant, seront r茅gl茅es le 15 ao没t 2025. Le prix d茅clar茅 est de $0 et le dossier mentionne 437,235 actions d茅tenues 脿 titre b茅n茅ficiaire apr猫s la transaction. Le formulaire est sign茅 par James E. Barnett, mandataire (Attorney-in-fact) le 08/12/2025.
Jason M. Hollar, ausgewiesen als Chief Executive Officer, reichte ein Form 4 f眉r Cardinal Health, Inc. (CAH) ein und meldete eine Transaktion mit Datum 08/12/2025. Die Einreichung weist einen Erwerb von 245,420 Stammaktien aus, die als Performance-Share-Einheiten verbucht wurden und die nach Angaben des Meldenden am 15. August 2025 abgewickelt werden. Der angegebene Preis betr盲gt $0 und das Formular nennt 437,235 Aktien, die nach der gemeldeten Transaktion wirtschaftlich gehalten werden. Das Formular ist am 08/12/2025 von James E. Barnett, Bevollm盲chtigter (Attorney-in-fact) unterschrieben.
FAQ
Who filed the Form 4 for Cardinal Health (CAH)?
What transaction is reported on the Form 4 dated 08/12/2025?
When will the performance share units settle?
What is the reported beneficial ownership after the transaction?
What price is reported for the acquisition?
